Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Gatzemeier, U
Bildat, S
Harstrick, A
Eberhardt, W
Achterrath, W
Krauss, C
Wilke, HJ
机构：
[1] Rhone Poulenc Rorer, Cologne, Germany
[2] W German Canc Ctr, Essen, Germany
[3] Krankenhaus, Grosshansdorf, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
448
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Phase I study of docetaxel in combination with gemcitabine as first line chemotherapy (CT) in patients with metastatic non-small cell lung cancer (NSCLC)
    Bildat, S
    Gatzemeier, U
    Reck, M
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S262 - S262
  • [2] Combination of docetaxel (DTX) and gemcitabine (G) in patients with inoperable or metastatic non-small cell lung cancer (NSCLC). A phase I study
    Rebattu, P
    Pujol, JL
    Ardiet, C
    Quentin, X
    Droz, JP
    Dumortier, A
    Khial, F
    Schuller, MP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 95 - 95
  • [3] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
  • [5] Oxaliplatin and docetaxel as first line chemotherapy for patients with non-small cell lung cancer (NSCLC).
    Santos, ES
    Raez, LE
    Rocha-Lima, C
    Tolba, K
    Negret, L
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, MF
    Wu, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 687S - 687S
  • [6] Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, D
    Lim, WT
    Subramanian, J
    Viswanathan, A
    Govindan, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [7] Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)
    William, W. N., Jr.
    Kies, M. S.
    Fossella, F. V.
    Gladish, G.
    Heymach, J. V.
    Glisson, B. S.
    Tse, W. H.
    Liu, D.
    Herbst, R. S.
    Lippman, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer
    Nishio, M
    Ohyanagi, F
    Taguch, F
    Matsuda, M
    Sato, Y
    Okumura, S
    Nakagawa, K
    Horai, T
    [J]. LUNG CANCER, 2005, 48 (01) : 115 - 119
  • [9] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [10] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
12345